FTC investigators documented how pharmacy benefit managers imposed eye-popping markups on generic drugs used to treat deadly ...

Opinion: Miami attorney Gregg Goldfarb says wielding antitrust, fraud, and nuisance claims can help attorneys score wins in ...

There's little point in pouring hundreds of millions of dollars into creating a biosimilar if PBMs will refuse to cover it.

Health Secretary Robert F. Kennedy Jr. looks poised to win the battle over fluoride, to the dismay of dentists and oral ...

Bil Schmidtknecht blames pharmacy benefit managers for the death of his son. He won’t rest until he holds them accountable.

PBMs appeal FTC case over insulin costs The FTC alleges anticompetitive and unfair rebating practices that artificially inflate the list price of insulin.

The One Big Beautiful Bill (OBBB), which passed on July 3 and is expected to be signed by President Donald Trump by July 4, ...

Kentucky law to give independent pharmacies financial relief from pharmaceutical industry middlemen has stalled in state ...

Healthcare analyst Ellen Andrews, Ph. D, highlights a first-in-the-nation bill that the state passed this year in an effort to control generic drug prices.

In a Kansas City Star guest commentary (6/25/25 page 14A), Jamie Corley, executive director of the nonprofit Prescription ...

AG Liz Murrill explains why Louisiana filed three major lawsuits against CVS over controversial text messages and business ...

The Federal Trade Commission announced this week that Care.com will refund more than $8 million to users nationwide after the company was found to have misled consumers and made it difficult for ...